Arterial hypertension in women with climacteric syndrome
Due to high prevalence of arterial hypertension (AH) in postmenopausal women, this problem has received much attention recently. Hormonal changes in perimenopause cause neuroendocrine disturbances, facilitating AH development and determining some AH features. In peri- and postmenopausal women, AH of...
Main Authors: | V. I. Podzolkov, L. G. Mozharova, Yu. V. Khomitskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2005-10-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1010 |
Similar Items
-
IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?
by: D. V. Nebieridze, et al.
Published: (2015-12-01) -
Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
by: V. V. Trusov, et al.
Published: (2007-08-01) -
Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01) -
Theory and practice of selective imidazoline receptor agonist use in Russia
by: N. I. Gaponova, et al.
Published: (2024-07-01) -
Imidazoline receptor agonists and left ventricular hypertrophy
by: L. L. Kirichenko, et al.
Published: (2005-04-01)